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There has been much uncertainty regarding the presence, variety, and maturity of 
T  cells in athymic mice. Placental passage of maternal T  cells cannot account for T 
cells in nu/nu progeny of nu/nu parents  (1, and unpublished observations), and there 
is good evidence against the hypothesis of a functional thymic rudiment (2). 
Prothymocytes, which are present equally in athymic and normal mice, are already 
committed to express the thymocyte surface phenotype and can be induced to do so 
by many nonspecific, as well as thymus-related, agents. Thus, nonspecific induction, 
attributable to incidental conditions, such as endemic viral hepatitis (3), which vary 
from one mouse colony to another, can explain some of the inconsistencies among 
published reports, at least as these concern surface phenotype. 
As regards function, nu/nu splenocytes, cultured under special conditions including 
provision  of interleukin  2  (IL-2) a  (4),  respond  to  T  cell  mitogens  and  allogeneic 
stimulator  cells  (mixed leukocyte culture)  and  can  yield cloned lines of allogeneic 
killer effector cells (5). It has even been suggested that lack of IL-2 could be the only 
primary deficiency resulting from lack of a thymus (6). 
In  the  present  study,  we  sought  to  define the  T  cell population  of nu/nu mice, 
specific pathogen free (SPF) or germ free, in more detail, according to the criteria of 
diversity of Ly sets and expression of the markers TL and Qa-1, and to see how the 
proportions of T  cells expressing these phenotypes may be affected by treatment with 
thymopentin (TP-5), a synthetic pentapeptide fragment of thymopoietin. 
Materials and Methods 
Mice.  SPF BALB-nu/nu and nu/+  mice were obtained at 4-5 wk of age from Gibco Animal 
Resources  Laboratories  (Madison,  WI).  These  mice  were  derived  from  the  fifth  backcross 
generation to the BALB-Bom strain. We found no differences in expression ofT cell markers in 
these mice and mice of the 20th backcross generation from the same source,  which were not 
available  in  quantity.  Mice  of  both  genotypes,  nu/nu  and  nu/÷,  were  maintained  under 
pathogen-free conditions in germ-free isolators and were tested periodically for the constancy 
of their bacterial  flora.  We  also  studied  pathogen-free  HSFS/N-nu  mice  (Tlaa:TL+:Qal+), 
germ-free HSFS/N-nu derived by caesarian section at the Sloan-Kettering Institute for Cancer 
Research,  and pathogen-free B6-nu/nu  (originally from Dr.  Carl T.  Hansen,  NIH),  all main- 
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1Abbreviations used in  this paper."  IL-2,  interleukin  2:  SPF,  specific  pathogen-free;  PBS,  Dulbecco's 
phosphate-buffered saline; sIg  ÷, surface immunoglobulin-positive; FCS, fetal calf serum; FITC, fluoresceine 
isothiocyanate; PA-SRBC, Staphylococcus  aureus protein A-coated sheep erythrocytes; TP-5, thyrnopentin. 
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tained at the Sloan-Kettering Institute. 
TP-5 Treatment.  The TP-5 synthetic pentapeptide fragment ofthymopoietin (7) was diluted 
to 2/lg/ml in phosphate-buffered saline (PBS) and filter sterilized. Mice aged 5  7 wk received 
intraperitoneally 0.5 ml of TP-5 (1 #g) five times/wk for 3 wk. Control mice were given either 
saline or a randomly synthetic control pentapeptide (8). Treated mice and controls were tested 
ld after cessation of treatment, when the mice were 8  10 wk of age. 
Antisera.  Monoclonal alloantibodies were used throughout, except for the Qa-1  antiserum, 
(B6 X A.TL  )F1 anti-A strain leukemia ASL1, absorbed as required according to Stanton and 
Boyse (9).  In tests for specificity, performed on concanavalin A-induced splenic blast cells to 
boost sensitivity, Q.a-1 antiserum was negative for B6 and positive for B6-Tla  '~ congenic, BALB, 
and  BALB-nu. The  positive  reaction  with  BALB  is  controversial and  is  being investigated 
further, but for present purposes it is sufficient to note that we have seen no difference between 
BALB/nu and HSFS/N-nu in reactivity with Q a-1 antiserum. 
Monoclonal antibody to Lyt-l.2 (clone 3-3.1) and TL (clone 79-10.4) were provided by Dr. 
F.-W. Shen; to Thy-l.2 (clone 937), Lyt-2.2 (clone 19/178) by Dr. U. Hiimmerling; and to Lyt- 
3.2 by Dr. M  Palladino (all of the Memorial Sloan-Kettering Cancer Center). Affinity-purified 
rabbit anti-mouse F(ab)2 was provided by Dr. U. H/immerling. 
Staphylococcus aureus Protein A-coated Sheep Erythrocyte  (PA-SRBC)  Assay.  This  assay  was 
performed according to Scheid and Triglia (10). Especially with antisera that require absorption 
of auto-  or  other  unwanted  antibody,  there  is  an  appreciable  background  of  nonspecific 
rosetting. This was abolished by routine centrifugation (30 rain at 130,000 g) of all antisera and 
monoclonal antibodies before use. Before being tested, all cell suspensions were incubated at 
37°C for 60 min and then washed two or three times to remove cytophilic antibody. 
Enrichment and Selection of T Cells.  Depletion of surface immunoglobulin-positive (sIg  +) cells 
was carried out on plastic dishes coated with affinity-purified rabbit anti-mouse F(ab)z (11). 
1-2 X  10 7 spleen cells in 3 ml of PBS with 5% fetal calf serum (FCS) were incubated at 4°C on 
antibody-coated 100 X 20-mm petri dishes (1005; Falcon Labware, Oxnard, CA). The nonad- 
herent  (T cell-enriched) fraction was harvested after  70-90 rain by multiple cycles of gentle 
rinsing of the monolayers with PBS-5% FCS.  10-20% of the nu/nu spleen cells and 30-40% of 
the  nu/÷  spleen  cells  were  recovered  in  the  nonadherent  fraction  with  <2-5%  sIg  +  cells 
remaining, as judged by fluorescein isothiocyanate (FITC) or PA-SRBC assay. The nonadherent 
portion  of nu/nu  spleen  cells  was  50-60%  Thy-I +  as  compared  with  80-90%  Thy-1 +  from 
nu/+ . 
No detectable loss ofT cells during the cell fractionation procedure was observed throughout 
these experiments, and < 1% Thy-1 + cells were found in the adherent population recovered by 
pipetting, as measured by direct immunofluorescence. In some experiments, further enrichment 
of the nu/nu T  cell populations (up to 80-95%)  was achieved by depletion of Ia  + and Lyb-2.2 
cells (some of which are sIg-) by sensitizing the unseparated spleen population with optimal 
concentrations of combined Ia and Lyb-2.2 antibodies, washing twice, and exposing to anti-Ig- 
coated dishes as above. 
Enumeration of Ly Sets.  Ly sets ofT cell-enriched spleen cells were estimated from PA-SRBC 
counts  with  anti-Lyt-1  antibody  alone,  anti-Lyt-2 antibody  alone,  and  the  two  antibodies 
combined (equalling total Lyt  + cells) (for controls and calculations see ref.  t2). The data for Ly 
sets are expressed  as percent of total  Lyt  + cells. Because Lyt-2 and Lyt-3 have not yet been 
found to be expressed independently, and anti-Lyt-2.2 and anti-Lyt-3.2 antibodies gave similar 
results, we generally used only the former. 
Results 
Proportions  of  TL:Qa-I:Lyt  T  Cell  Sets  in  nu/nu  and  nu/+  Mice  as  a  Function  of 
Age.  Despite  reports  that  BALB/c  mice are  Qa-1 b  (13),  we  found  that  the  BALB- 
nu/+  and BALB-nu/nu  mice we used, like mice of our BALB/c colony, are Q a-la; this 
was  established  by the  PA-SRBC  assay  with  concanavalin A-induced blast  cells as 
targets, and was confirmed by specific absorption. 
Neither we  (3)  nor others  (14)  have previously succeeded in demonstrating signifi- 
cant numbers of Thy-l+:Lyt + splenocytes in germ-free or SPF young nu/nu mice (<2 RANGES  ET  AL.  1059 
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FIG.  1.  Expression of Thy-1 on spleen cells from BALB/nu/nu  (  )  and nu/+  (- -  -)  mice. Age- 
and sex-matched nu/nu and nu/+  mice were assayed for Thy- 1 expression. Each time point represents 
the average of two to eight pairs of mice. 
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Fro.  2.  Expression of TL and Qa-1 on spleen cells from BALB/nu/nu  (  ) and nu/+  (- -  -) mice 
(see Fig, [). Data expressed as percent ofThy-1 + cells. 
mo of age). However, the use of a  highly sensitive PA-SRBC rosette assay together 
with a  preparatory T  cell-enrichment procedure, not encountering significant T  cell 
losses, allows the reliable detection of such cells in 6-wk-old mice and their character- 
ization with respect to TL, Qa-1, and Ly phenotypes. As seen in Fig.  1, for mice of 6- 
16 wk of age the number ofT cells in nu/nu spleen was only 20-50% of the number in 
nu/+ spleen. Like all normal mice, nu/+  mice have no TL  + cells in spleen, (Fig. 2, left 
panel), whereas the Thy-1 ÷ T  cells of spleen of nu/nu mice are TL  +, in proportions of 
-100% TL  ÷ cells during the first  10 wk after birth, falling to 8-10% at  16 wk of age. 
The availability of monoclonal TL antibody makes it possible to count TL  ÷ cells and 
Qa-I+:TL  -  cells separately. Previously it was necessary to use the same conventional 
antiserum [(B6 ×  A-Tlab)anti-ASL1] for typing of both TL on thymocytes and Q a-1 
on peripheral T  cells. The proportion of Qa-I+:TL  -  cells in nu/nu and nu/+ spleens 
was deduced  by subtracting the count for monoclonal TL antibody from the count 
for conventional TL antiserum. Clearly, this still does not allow distinction of cells of 
possible TL  +:Qa- 1  + and TL+:Qa  - 1- phenotypes. 
As the right-hand panel of Fig. 2 shows, the proportion ofThy-1 ÷ spleen cells that 
were  Qa-I+:TL  -  in  nu/+ controls  remained  constant  (~30%)  throughout  the  age 
range studied (4-16 wk), as compared with 0% in nu/nu mice until  10 wk of age, rising 
thereafter to ~70% at  16 wk. 
The  uniformly  TL  +  splenic  T  cells  of nu/nu aged  <10  wk  (Fig.  2,  left  panel) 
evidently all belong to the Ly-123 set (Fig. 3, lower panel). At 10-16 wk of age, during 
which  the proportion of TL  + cells fell to <10%  of total splenic Thy-1 +  (Fig.  2, left 
panel),  there  was  corresponding  diversification  into  Lyl  and  Ly23  sets.  As  Fig.  3 
shows, the proportional representation of Ly-123, Ly-1, and Ly-23 sets in BALB nu/nu 
spleen at  14-16 wk of age was roughly similar to the proportions already reached by 
nu/+  and other normal mice at 4 wk of age (Fig. 3, and other data not shown). 1060  T  CELL  DEVELOPMENT  IN  NUDE  MICE 
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Fie.  3.  Age-related Lyt set aherations in spleens from BALB/nu/nu ( 
(see Fig. 1). 
) and nu/+  (- - -) mice 
In  summary,  there are three salient differences between  nu/nu  and  nu/+  mice as 
regards the composition of their T  cell populations during the later age period studied, 
16 wk onward, and these are (a) a  lower total number of T  cells, (b) persistence of 5- 
10% TL + splenic T  cells, and  (c)  a  greatly raised proportion of Qa-1 + T  cells. All the 
data  described above for  BALB-nu  mice  have  been  duplicated, with  no  significant 
differences, for HSFS/N-nu and B6-nu mice, except that the latter are of Tla  b genotype 
and therefore cannot be scored for TL and Qa-1. A  recent report from MacDonald et 
al.  (14)  also describes the presence of Thy-l+:Lyt-l+:2- cells in the spleens of older 
but  not  younger nu/nu  mice  (>6  mo of age)  detected by  fluorescence-activated cell 
sorter  (FACS)  analysis  of nylon  wool-purified T  cells.  In  contrast  to  our  findings 
reported here, these investigators did not identify this or other T  cell populations in 
younger nu/nu  mice. This is most  likely caused by the significant preparatory T  cell 
loss (50%)  encountered  (15). 
Effect  of Treatment  with  TP-5  on  T  Cell  Set  Composition  of nu/nu  Mice.  TP-5  is  a 
synthetic pentapeptide fragment of thymopoietin. To  test its effect on  the T  cell set 
composition of nu/nu mice, TP-5 was administered repeatedly to pathogen-free BALB 
nu/nu and nu/+  mice, beginning at 5-7 wk of age and ending at 7-10 wk of age. The 
data  shown  are  for  the  BALB-nu  strain,  and  were  duplicated  with  no  significant 
differences for HSFS/N-nu mice. The lower part of Table I shows that treatment with 
TP-5 had no significant effect on the T  cell set composition of nu/+  mice. The upper 
part of Table I  shows the effects of TP-5 in nu/nu mice. First, the total number of T 
cells, classified as Thy-1 + and Lyt  +, rose from <9%  of splenocytes in untreated mice 
to >20% in TP-5-treated mice, but did not reach the >35% ofnu/+  mice. Second, the 
proportion ofTL + splenic T  cells fell from 97% to 26%, but not to the 0% recorded for 
TP-5-treated nu/+  mice.  Third,  the  proportion  of Qa-1 + T  cells rose from  ~3%  to RANGES  ET  AL. 
TABLE  I 
Effect of TP-5 on the Splenic T Cell Population of nu/nu and nu/+  Mice* 
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Phenotypes 
Genotype  B cell- 
of cell  Treatment  Unseleeted splenocytes  depleted  Thy-I  ÷ splenocytes 
donor  splenocytes 
Thy-1 +  Lyt+:[:  Thy-1 +  TL  +  TL-:Qa- 1  + 
% ± SEAt 
TP-5  21.7 +  1.4  21.0  ±  1.1  57.8 ±  5.1  26.2 ±  3.9  33.8 ±  10.6 
nu/nu  Control§  8.8 ±  1.8  8.6 ±  0.8  51.0  ±  4.3  97.0  ±  1.5  3.1  ±  0.7 
TP-5  38.3 ±  1.4  38.6 ±  2.0  85.8  +  2.7  0  36.6 +  3.7 
nu/+  Control§  36.5 -  1.3  37.5 ±  1.5  84.1  ±  1.3  0  33.3 +  2.6 
* In the study shown, TP-5 treatment was begun at 5 wk of age and continued until testing (as shown) at 
8  wk of age.  Eight  mice in each group matched  for age and sex were tested  as single pairs to reduce 
technical variation. (The Lyt set analysis for these mice is given in Fig. 4.) 
Positive reactivity with a  Lyt-1  and a  Lyt-2 sera combined. 
§ Controls received either the TP-5 solvent medium alone or a random-sequence pentapeptide in place of 
TP-5;  these control data are combined because there was no significant difference. 
Control  TP-5 
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Fro.  4.  Diversification  of Lyt  subsets  (Ly-123  (['7); Ly-23  (11); Ly-1  (D)  induced by TP-5  in 
BALB/nu/nu mice (see legend to Table I). 
~34%,  which  is  within  the  normal  range  for  nu/+  and  other  mice.  As  regards 
diversification, Fig. 4 shows extensive differentiation  into Lyt sets  (roughly 45% Ly- 
123, 5% Ly-23, 50% Ly-1) in response to TP-5. 
Discussion 
The main features of splenic T  cell development in SPF and germ-free nude mice, 
according to the criteria of surface phenotypes, reported here, can be summarized as 
follows: The total number of T  cells is diminished to ~25% rising to 50% of normal. 
Until  10 wk of age, all splenic T  cells are TL  +, and there is little or no diversification 
into Ly-1 and Ly-23 sets--all are Ly-123. After  10 wk of age, the proportion of TL  + 
T  cells declines, diversification into Ly-1 and Ly-23 cell sets begins, and there is an 
increasingly excessive ratio of Qa-1 + to Qa-1- cells. 
Only  since  monoclonal  TL  antibodies  became available has  it  been  possible  to 
distinguish with certainty between TL  ÷ and Q a-1 + cells. The finding of TL  + cells in 
nu/nu (but not in nu/+ )  spleen is a striking abnormality that we are studying further. 
The only previously reported occurrence ofextrathymic TL  + cells, excepting leukemia, 
concerned heavily irradiated mice (16). 1062  T  CELL  DEVELOPMENT  IN  NUDE  MICE 
Treatment with TP-5 during the 5th-8th wk of age rectifies, at least partially, some 
of the abnormalities noted.  Thus the number of splenic T  cells rises, the number of 
TL  + cells falls, and diversification into Ly-1 and Ly-23 sets is initiated;  these changes 
towards the normal also occur in older mice not treated with TP-5. It remains to be 
seen whether other regimens of TP-5 therapy are more effective in this regard, and 
whether such  treatment  may counter the excessive Qa-l+:Qa-1 -  cell ratio, which  is 
not  grossly  evident  under  16  wk  of age.  The  possibility  that  the  Q.a-1  system  is 
compound and  the lack of monoclonal  Qa-1  antibodies  are obstacles to the precise 
interpretation  of Qa-1 + counts and ratios.  This is unfortunate,  particularly because 
Qa-1 expression is associated with generation of help and suppression (17) and perhaps 
because Qa-1 expression is enhanced or initiated on mitogen-stimulated cells, which 
resemble nu/nu cells in terms of their blastoid appearance and light scatter (18). 
At present, little can be said about the mode of action of TP-5 in nude  mice. In 
vitro, TP-5 induces  prothymocytes to express the TL+:Ly-123 phenotype typical of 
early thymocytes, and prothymocytes are present  in normal numbers in  nude  mice 
(7).  But it seems unlikely that  induction  of prothymocytes can be the only effect of 
TP-5 because nude mice already have appreciable numbers of TL+:Ly-123 cells.  It 
may be that TP-5, over a period longer than the standard 2-h induction assay, drives 
the differentiative sequence  further to yield the TL- sets Ly-123,  Ly-1, and  Ly-23. 
This would  be in  accord with  the fact that  TP-5  reduces  the absolute and relative 
number of TL  ÷ cells while increasing the total number of T  cells, but such a  direct 
effect has yet to be demonstrated. Alternatively, there is a precedent for more complex 
action in the observation that CR  + splenic cell numbers are increased in nu/nu mice 
by treatment with TP-5, although TP-5 inhibits the differentiative induction of pro- 
CR  + cells in vitro (7). 
It  is  too  early to  report  on  tests  of immune  function  of cells  from TP-5-treated 
nu/nu mice. With respect to weak homograft reactivity (H-Y), TP-5 therapy alters the 
responses of aged mice and mice thymectomized in young adult life, tending to restore 
the rejection pattern  (19)  and T  cell population  structure  typical of normal young 
adults.  At the moment, we cannot  point  to a  cell of any known surface phenotype 
that is lacking in athymic nu/nu mice, which favors the view that the thymus functions 
in  maintaining  the  numbers  and  homeostatic  balance  of T  cell  sets,  rather  than 
directing differentiative steps that cannot otherwise occur. 
Summary 
The extent and diversity ofT cell differentiation in nude athymic mice are matters 
of dispute. In this study, we examined the splenic Tcell population of pathogen-free 
and germ-free nu/nu mice, treated or not treated with the pentapeptide analogue of 
thymopoietin (TP-5), in terms of TL, Qa-1, and Lyt phenotypes. 
At all ages, 50-60% of nu/nu splenocytes, enriched for T  lymphocytes by removal of 
sIg  + cells, expressed T  markers, as compared with >85% in normal mice. At 2 mo of 
age,  all nu/nu splenic  T  cells expressed the  surface phenotype TL÷:Thy-l+:Ly-123. 
This is abnormal in two respects: first, because expression of TL is normally confined 
to thymocytes; and second, because there was no evidence of the usual diversification 
into the subsets Ly-1 and Ly-23. 
From  10 wk of age onwards,  diversification into  Ly subsets was evident  in nu/nu 
spleen, although the usual predominance of Ly-1 over Ly-123 cells was not attained, RANGES  ET  AL.  1063 
and some TL + cells persisted. Also, the ratio ofQa-1 ÷ to Qa-1- cells rose progressively 
to as high as 4:1  at 4-6 too, in contrast to the usual ratio of ~  1:1, regardless of age. 
In the spleens of nu/nu mice treated with TP-5 from 5-8 weeks of age and tested  1 wk 
later, the proportion of T  cells was raised, though not to normal levels, the number of 
TL  + cells was reduced, and there was diversification into Ly sets. 
Received  for publication 21 June 1982. 
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